Get started
Author

Shiva Krupa

The BioPAX community standard for pathway data sharing
2010 · Emek Demir, Michael P Cary, et al. · Nature Biotechnology · 737
PDF
Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2016 · Andrew C. Wood, Kateryna Krytska, et al. · Clinical Cancer Research · 98
PDF
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
2016 · Lori S. Hart, JulieAnn Rader, et al. · Clinical Cancer Research · 81
The NCI-Nature Pathway Interaction Database: A cell signaling resource.
2007 · Kira Anthony, Shiva Krupa, et al. · Nature Precedings · 26
Erratum: Corrigendum: The BioPAX community standard for pathway data sharing
2010 · Emek Demir, Michael P Cary, et al. · Nature Biotechnology · 22
PDF
A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector
2022 · Monica Alvisi, Timothy Henry, et al. · Journal of Molecular and Cellular Cardiology · 4
Erratum: Corrigendum: The BioPAX community standard for pathway data sharing
2012 · Emek Demir, Michael P Cary, et al. · Nature Biotechnology · 4
PDF
Supplementary Figure 3 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 1 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 4 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 3 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 2 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Figure 1 and 2 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Figure 4 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Online Supplementary Tables from Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
2023 · Lori S. Hart, JulieAnn Rader, et al.
Supplementary Figure Legend from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Figures from Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
2023 · Lori S. Hart, JulieAnn Rader, et al.
Supplementary Figure Legend from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Information from Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma
2023 · Lori S. Hart, JulieAnn Rader, et al.
Supplementary Figure 1 and 2 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 4 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Figure 4 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Figure 3 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 1 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Supplementary Table 3 from Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma
2023 · Andrew C. Wood, Kateryna Krytska, et al.
Works count: 36
Citation count: 972
H-index: 5
I10-index: 5
Year
Topic
Type